Literature DB >> 3652009

Use of nude mouse xenografts as preclinical screens. Characterization of xenograft-derived melanoma cell lines.

R Taetle1, O W Jones, J M Honeysett, I Abramson, C Bradshaw, S Reid.   

Abstract

Cell lines derived from human melanoma xenografts were characterized for surface markers, karyotype abnormalities, and in vitro drug sensitivity. Xenografts were established using metastatic explants from untreated patients and passaged in nude mice. Cell lines were readily established from melanoma xenografts, and formed colonies when plated in semisolid media. The lines expressed human melanoma-associated and other surface antigens, human lactate dehydrogenase (LDH) isoenzymes, and contained only human chromosomes. They failed to express murine histocompatibility determinants and were negative for murine viruses by mouse antibody production assay. Karyotypes showed abnormalities of chromosomes 3, 6, and 7 similar to other melanomas. In vitro chemosensitivity profiles were compared using cell line and xenograft colony-forming assays. Values were similar for the original xenografts and their cell lines. Xenograft-derived human melanoma lines resemble other melanoma cell lines and primary melanomas with respect to surface antigens and karyotype abnormalities, and are appropriate models for studying in vitro drug sensitivity. When used as a model for transition from solid tumor to cell line, these studies suggest cell lines closely mirror in vitro chemosensitivities of parent tumor cells. However, occasional, unpredictable changes in sensitivity to some drugs occurs during this transition.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3652009     DOI: 10.1002/1097-0142(19871015)60:8<1836::aid-cncr2820600827>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

Review 1.  Patient-derived tumour xenografts as models for oncology drug development.

Authors:  John J Tentler; Aik Choon Tan; Colin D Weekes; Antonio Jimeno; Stephen Leong; Todd M Pitts; John J Arcaroli; Wells A Messersmith; S Gail Eckhardt
Journal:  Nat Rev Clin Oncol       Date:  2012-04-17       Impact factor: 66.675

2.  Human pancreatic leiomyosarcoma (PZX-7) growing as a serially transplantable xenograft in immunosuppressed mice.

Authors:  A Zalatnai; J Bocsi; T Csákány; T Fekete; J Lásztity
Journal:  Int J Pancreatol       Date:  1999-08

3.  Therapeutic implications of melanoma heterogeneity.

Authors:  Stephanie J Hachey; Alexander D Boiko
Journal:  Exp Dermatol       Date:  2016-05-19       Impact factor: 3.960

Review 4.  Xenograft and organoid model systems in cancer research.

Authors:  Margit Bleijs; Marc van de Wetering; Hans Clevers; Jarno Drost
Journal:  EMBO J       Date:  2019-07-08       Impact factor: 11.598

5.  Expression of the zinc finger gene EVI-1 in ovarian and other cancers.

Authors:  D J Brooks; S Woodward; F H Thompson; B Dos Santos; M Russell; J M Yang; X Y Guan; J Trent; D S Alberts; R Taetle
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

6.  Enhancement of drug sensitivity of human malignancies by epidermal growth factor.

Authors:  R Kröning; J A Jones; D K Hom; C C Chuang; R Sanga; G Los; S B Howell; R D Christen
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

7.  Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell lines.

Authors:  E F McClay; K D Albright; J A Jones; R D Christen; S B Howell
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

8.  Comparison of the types of candidate reference samples for quality control of human epidermal growth factor receptor 2 status detection.

Authors:  Yulong Li; Rui Zhang; Yanxi Han; Tian Lu; Jiansheng Ding; Kuo Zhang; Guigao Lin; Jiehong Xie; Jinming Li
Journal:  Diagn Pathol       Date:  2016-09-10       Impact factor: 2.644

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.